SCHEMBL5281059

SCHEMBL5281059

CON(c1ccccc1)[C@@H](CO)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
TSHR P16473 2/20 0.38
GLA P06280 1/20 0.38
SMPD2 O60906 1/20 0.37
MTNR1A P48039 3/20 0.37
MTNR1B P49286 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
TP53 P04637 2/20 0.37
LMNA P02545 1/20 0.37
NPSR1 Q6W5P4 2/20 0.35
KMT2A Q03164 4/20 0.35
MEN1 O00255 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
KDM4E B2RXH2 1/20 0.35
HPGD P15428 1/20 0.35
CHRNB2 P17787 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5281056 1.00 ALDH1A1 (0.38) ALDH1A1TSHRGLASMPD2MTNR1A
SCHEMBL7424666 0.83 CYP1A2 (0.46) ALDH1A1KMT2AMEN1CYP2C9CYP2C19
SCHEMBL7424670 0.83 CYP1A2 (0.46) ALDH1A1KMT2AMEN1CYP2C9CYP2C19
SCHEMBL12985477 0.80 KMT2A (0.41) ALDH1A1SMN1; SMN2LMNAKMT2AMEN1
SCHEMBL3963076 0.77 KMT2A (0.45) ALDH1A1MTNR1AMTNR1BSMN1; SMN2KMT2A
SCHEMBL679865 0.77 ALDH1A1 (0.41) ALDH1A1TSHRGLASMPD2SMN1; SMN2
SCHEMBL27820012 0.77 ALDH1A1 (0.41) ALDH1A1TSHRGLASMPD2SMN1; SMN2
SCHEMBL3199580 0.77 KMT2A (0.41) ALDH1A1TSHRGLASMN1; SMN2TP53
SCHEMBL4564576 0.77 ALDH1A1 (0.41) ALDH1A1TSHRGLASMPD2SMN1; SMN2
SCHEMBL21776703 0.76 NPSR1 (0.41) ALDH1A1TSHRGLASMPD2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403645-B2 Antidepressant effect of norepinephrine uptake 2 inhibitors and combined medications including them PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2002-06-11 US claimed
US-20070116643-A1 Novel aryloxypropanamines CONCERT PHARMACEUTICALS INC. (US) 2007-05-24 US disclosed
WO-2007005644-A2 NOVEL ARYLOXYPROPANAMINES CONCERT PHARMACEUTICALS INC. (US) 2007-01-11 WO disclosed